GBP1 was silenced in MDA-MB-231 and in MDA-MB-231-BM breast cancer cell lines using pooled probes against GBP1. However, the expression of GBP1 was not affected when using siSham (negative control) (Fig. 4a). The gene discussed is GBP1; the disease is breast carcinoma.